Back to the main directory
EarningsReview / Equity
- The Recipe for $80+ Power (and 80%+ More Upside) by BNP Paribas Exane
- Taxing times: potential UK budget impacts by BNP Paribas Exane
- We like Adyen and Visa into CQ3 by BNP Paribas Exane
- Stalling momentum - Q3 previews by BNP Paribas Exane
- LatAm Auto Insurance by HSBC
- Non material data changes by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Chinese stimulus impact: delaying gratification by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- CHINA MACRO, CHINA INFLATION, CHINA TRADE, STEEL CHINA, MT, X by BNP Paribas Exane
- Argent Biopharma - Valuation report by Edison Investment Research
- US Election - How to trade it? by BNP Paribas Exane
- JPMorgan European Discovery Trust - European small caps: On the verge of a rebound? by Edison Investment Research
- Diverse Income Trust (The) - Could be the time for UK equities to shine by Edison Investment Research
- Izertis - Reassuring 1H24 results support growth story; Buy by JB Capital Markets
- Non material data changes by BNP Paribas Exane
- More than a Sporting Chance by BNP Paribas Exane
- Q3 Pre-close feedback by BNP Paribas Exane
- Arctic Bioscience (Hold, TP: NOK15.00) - HeROPA-trial results by DnB Markets
- Valmet (Buy, TP: EUR32.00) - 2024 profit warning by DnB Markets
- Tomra (Sell, TP: NOK95.00) - Next stop, Poland by DnB Markets
- Kesko (Buy, TP: EUR20.00) - Undervalued earnings recovery by DnB Markets
- DNO (Buy, TP: NOK15.00) - Q3 update on the soft side by DnB Markets
- Lundbeck (Buy, TP: DKK55.00) - Executing on M&A agenda by DnB Markets
- Petrobras set to reduce 2025 capex by DnB Markets